Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study

CONCLUSION: In this real-world setting, newer DMTs showed better efficacy than interferon beta-1a on ARR and risk of new T2 lesions, with a good safety profile. Natalizumab tend to emerge as the most effective treatment.PMID:37245449 | DOI:10.1016/j.ejpn.2023.05.001
Source: European Journal of Paediatric Neurology - Category: Neurology Authors: Source Type: research